| 1 |
25394093 | CSF LPV concentrations and viral load in viral suppressed patients on LPV/r monotherapy given once daily. | 2014 |
1 |
| 2 |
23260386 | [Comparative cost-effectiveness analysis between darunavir/ritonavir and other protease inhibitors in treatment-naive human immunodeficiency syndrome type 1-infected patients in Spain]. | 2013 Aug-Sep |
1 |
| 3 |
21719718 | Pharmacokinetics and safety of the lopinavir/ritonavir tablet 500/125 mg twice daily coadministered with efavirenz in healthy adult participants. | 2012 Aug |
3 |
| 4 |
20192725 | Comparison of once-daily versus twice-daily combination antiretroviral therapy in treatment-naive patients: results of AIDS clinical trials group (ACTG) A5073, a 48-week randomized controlled trial. | 2010 Apr 1 |
1 |
| 5 |
21182349 | Cost effectiveness of darunavir/ritonavir 600/100 mg bid in treatment-experienced, lopinavir-naive, protease inhibitor-resistant, HIV-infected adults in Belgium, Italy, Sweden and the UK. | 2010 |
2 |
| 6 |
14731164 | A prospective, controlled study assessing the effect of lopinavir on amprenavir concentrations boosted by ritonavir. | 2004 Jan |
2 |